Literature DB >> 10712693

Multiple N-acetyl neuraminic acid synthetase (neuB) genes in Campylobacter jejuni: identification and characterization of the gene involved in sialylation of lipo-oligosaccharide.

D Linton1, A V Karlyshev, P G Hitchen, H R Morris, A Dell, N A Gregson, B W Wren.   

Abstract

N-acetyl neuraminic acid (NANA) is a common constituent of Campylobacter jejuni lipo-oligosaccharide (LOS). Such structures often mimic human gangliosides and are thought to be involved in the triggering of Guillain-Barré syndrome (GBS) and Miller-Fisher syndrome (MFS) following C. jejuni infection. Analysis of the C. jejuni NCTC 11168 genome sequence identified three putative NANA synthetase genes termed neuB1, neuB2 and neuB3. The NANA synthetase activity of all three C. jejuni neuB gene products was confirmed by complementation experiments in an Escherichia coli neuB-deficient strain. Isogenic mutants were created in all three neuB genes, and for one such mutant (neuB1) LOS was shown to have increased mobility. C. jejuni NCTC 11168 wild-type LOS bound cholera toxin, indicating the presence of NANA in a LOS structure mimicking the ganglioside GM1. This property was lost in the neuB1 mutant. Gas chromatography-mass spectrometry and fast atom bombardment-mass spectrometry analysis of LOS from wild-type and the neuB1 mutant strain demonstrated the lack of NANA in the latter. Expression of the neuB1 gene in E. coli confirmed that NeuB1 was capable of in vitro NANA biosynthesis through condensation of N-acetyl-D-mannosamine and phosphoenolpyruvate. Southern analysis demonstrated that the neuB1 gene was confined to strains of C. jejuni with LOS containing a single NANA residue. Mutagenesis of neuB2 and neuB3 did not affect LOS, but neuB3 mutants were aflagellate and non-motile. No phenotype was evident for neuB2 mutants in strain NCTC 11168, but for strain G1 the flagellin protein from the neuB2 mutant showed an apparent reduction in molecular size relative to the wild type. Thus, the neuB genes of C. jejuni appear to be involved in the biosynthesis of at least two distinct surface structures: LOS and flagella.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712693     DOI: 10.1046/j.1365-2958.2000.01780.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  44 in total

Review 1.  Flagellin glycosylation with pseudaminic acid in Campylobacter and Helicobacter: prospects for development of novel therapeutics.

Authors:  Abu Iftiaf Md Salah Ud-Din; Anna Roujeinikova
Journal:  Cell Mol Life Sci       Date:  2017-10-27       Impact factor: 9.261

2.  Genomic and metabolic profiling of nonulosonic acids in Vibrionaceae reveal biochemical phenotypes of allelic divergence in Vibrio vulnificus.

Authors:  Amanda L Lewis; Jean-Bernard Lubin; Shilpa Argade; Natasha Naidu; Biswa Choudhury; E Fidelma Boyd
Journal:  Appl Environ Microbiol       Date:  2011-07-01       Impact factor: 4.792

3.  Characterization of the Campylobacter jejuni heptosyltransferase II gene, waaF, provides genetic evidence that extracellular polysaccharide is lipid A core independent.

Authors:  Neil J Oldfield; Anthony P Moran; Lorna A Millar; Martina M Prendergast; Julian M Ketley
Journal:  J Bacteriol       Date:  2002-04       Impact factor: 3.490

4.  Comparison of Campylobacter jejuni lipooligosaccharide biosynthesis loci from a variety of sources.

Authors:  Craig T Parker; Sharon T Horn; Michel Gilbert; William G Miller; David L Woodward; Robert E Mandrell
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

5.  Whole genome comparison of Campylobacter jejuni human isolates using a low-cost microarray reveals extensive genetic diversity.

Authors:  N Dorrell; J A Mangan; K G Laing; J Hinds; D Linton; H Al-Ghusein; B G Barrell; J Parkhill; N G Stoker; A V Karlyshev; P D Butcher; B W Wren
Journal:  Genome Res       Date:  2001-10       Impact factor: 9.043

6.  Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro.

Authors:  Patricia Guerry; Christine M Szymanski; Martina M Prendergast; Thomas E Hickey; Cheryl P Ewing; Dawn L Pattarini; Anthony P Moran
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

7.  Changes in flagellin glycosylation affect Campylobacter autoagglutination and virulence.

Authors:  Patricia Guerry; Cheryl P Ewing; Michael Schirm; Maria Lorenzo; John Kelly; Dawn Pattarini; Gary Majam; Pierre Thibault; Susan Logan
Journal:  Mol Microbiol       Date:  2006-04       Impact factor: 3.501

8.  The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome.

Authors:  Peggy C R Godschalk; Astrid P Heikema; Michel Gilbert; Tomoko Komagamine; C Wim Ang; Jobine Glerum; Denis Brochu; Jianjun Li; Nobuhiro Yuki; Bart C Jacobs; Alex van Belkum; Hubert P Endtz
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

9.  Characterization of N-acetylneuraminic acid synthase isoenzyme 1 from Campylobacter jejuni.

Authors:  Appavu K Sundaram; Lee Pitts; Kamilah Muhammad; Jing Wu; Michael Betenbaugh; Ronald W Woodard; Willie F Vann
Journal:  Biochem J       Date:  2004-10-01       Impact factor: 3.857

10.  Simple sequence repeats in Helicobacter canadensis and their role in phase variable expression and C-terminal sequence switching.

Authors:  Lori A S Snyder; Nicholas J Loman; James D Linton; Rebecca R Langdon; George M Weinstock; Brendan W Wren; Mark J Pallen
Journal:  BMC Genomics       Date:  2010-01-27       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.